Novartis Investigative Site

Pico Rivera, California 90660

0 studies enrolling now · 2 studies all time

What they study most

Major Depressive Disorder, Schizophrenia

Studies at this site

• A Study to Evaluate the Effects of Once Daily Doses of AQW051 on Cognition, in Stable Schizophrenia Patients — Completed
• A Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine (25 or 50 mg) in the Treatment of Major Depressive Disorder (MDD) — Completed